Insider Trading Summary (Last 30 Days)

See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.

Transactions

1

Insider Involved

1

Total Buys

$0.00

Total Sells

$5.28M

Insider Trading History (Last 12 Months)

Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.

DATE

INSIDER

INSIDER TYPE SHARES PRICE

SHARES

PRICE

VALUE

Nov 17, 2026

PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG

PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG
EVP & Chief Admin Officer
Sell
20,000 $263.89

20,000

$263.89

$5,277,720

Sep 08, 2026

Bodenhoff Mads

Bodenhoff Mads
SVP & PAO
Sell
3,000 $270.19

3,000

$270.19

$810,570

Aug 14, 2026

BIENAIME JEAN JACQUES

BIENAIME JEAN JACQUES
Buy
1,100 $245.85

1,100

$245.85

$270,435

Aug 14, 2026

BIENAIME JEAN JACQUES

BIENAIME JEAN JACQUES
Buy
900 $246.91

900

$246.91

$222,219

Jun 02, 2026

SMITH SCOTT THOMAS

SMITH SCOTT THOMAS
EVP & CHIEF FINANCIAL OFFICER
Buy
100 $219.00

100

$219.00

$21,900

May 29, 2026

BIENAIME JEAN JACQUES

BIENAIME JEAN JACQUES
Buy
200 $223.76

200

$223.76

$44,752

May 29, 2026

BIENAIME JEAN JACQUES

BIENAIME JEAN JACQUES
Buy
200 $222.30

200

$222.30

$44,460

May 29, 2026

BIENAIME JEAN JACQUES

BIENAIME JEAN JACQUES
Buy
100 $223.50

100

$223.50

$22,350

May 29, 2026

SMITH SCOTT THOMAS

SMITH SCOTT THOMAS
EVP & CHIEF FINANCIAL OFFICER
Buy
250 $223.32

250

$223.32

$55,830

May 26, 2026

BIENAIME JEAN JACQUES

BIENAIME JEAN JACQUES
Buy
200 $236.24

200

$236.24

$47,247

May 26, 2026

BIENAIME JEAN JACQUES

BIENAIME JEAN JACQUES
Buy
200 $239.37

200

$239.37

$47,874

May 11, 2026

JENSEN FLEMMING STEEN

JENSEN FLEMMING STEEN
See Remarks
Sell
19,460 $238.49

19,460

$238.49

$4,641,021

Historical Insider Trading

View older insider trading records reported to the SEC to research long-term buying and selling trends.

No Historical Insider Transactions found for Ascendis Pharma A/S